Wanjia Group Holdings Limited (0401.HK) Stock
Wanjia Group Holdings Limited operates as an investment holding company, primarily engaged in the wholesale and distribution of pharmaceutical products across mainland China and Hong Kong. The firm also offers hemodialysis treatment and associated consultancy services.
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Ownership
Peer Comparison
About Wanjia Group Holdings Limited
Wanjia Group Holdings Limited operates as an investment holding company, primarily engaged in the wholesale and distribution of pharmaceutical products across mainland China and Hong Kong. The firm also offers hemodialysis treatment and associated consultancy services. Its pharmaceutical goods are supplied to a diverse client base within Fujian province, including hospitals, various healthcare institutions, pharmaceutical retail chains, independent pharmacies, outpatient departments of community hospitals, healthcare service stations, and clinics. Established in 2004, the company is headquartered in Kowloon, Hong Kong.
Wanjia Group Holdings Limited is led by CEO Jia Jun Wang, employs 183 people, headquartered in Hong Kong, HK, publicly traded since 2013.
over the past 52 weeks the stock has ranged between $0.07 and $0.21, and currently trades 52.4% below its 52-week high.
Official website: www.wanjia-gp.com